ResMed (RMD) News Today → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free RMD Stock Alerts $218.57 -1.40 (-0.64%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 10:19 AM | insidertrades.comWitte Jan De Sells 360 Shares of ResMed Inc. (NYSE:RMD) StockMay 18 at 7:24 AM | marketbeat.comJanney Montgomery Scott LLC Has $13.29 Million Stock Holdings in ResMed Inc. (NYSE:RMD)Janney Montgomery Scott LLC raised its position in ResMed Inc. (NYSE:RMD - Free Report) by 785.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,238 shares of the medical equipment proviMay 17 at 6:03 PM | marketbeat.comWealth Advisory Solutions LLC Sells 16,825 Shares of ResMed Inc. (NYSE:RMD)Wealth Advisory Solutions LLC lessened its holdings in ResMed Inc. (NYSE:RMD - Free Report) by 47.9% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 18,312 shares of the medical equipment provider's stock after selling 16,825May 16 at 5:55 PM | marketbeat.comBaader Bank Aktiengesellschaft Purchases 25,379 Shares of ResMed Inc. (NYSE:RMD)Baader Bank Aktiengesellschaft raised its holdings in shares of ResMed Inc. (NYSE:RMD - Free Report) by 1,308.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,319 shares of the medical equipment provider's stockMay 16 at 4:35 PM | globenewswire.comATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP TherapyMay 16 at 7:09 AM | marketbeat.comResMed Q3 Earnings TranscriptMay 15 at 7:19 AM | finance.yahoo.comZacks.com featured highlights BellRing Brands, ResMed, NVIDIA and TransdigmMay 14, 2024 | marketbeat.comResMed Inc. (NYSE:RMD) Shares Acquired by Ieq Capital LLCIeq Capital LLC boosted its position in ResMed Inc. (NYSE:RMD - Free Report) by 84.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 11,279 shares of the medical equipment provider's stock after purchasing anMay 14, 2024 | msn.com3 reasons ResMed shares 'are just too cheap!'May 13, 2024 | marketbeat.comResMed Inc. (NYSE:RMD) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. trimmed its holdings in ResMed Inc. (NYSE:RMD - Free Report) by 7.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 60,751 shares of the medical equipment provider's stock afteMay 12, 2024 | marketbeat.comMawer Investment Management Ltd. Buys Shares of 22,090 ResMed Inc. (NYSE:RMD)Mawer Investment Management Ltd. acquired a new stake in shares of ResMed Inc. (NYSE:RMD - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 22,090 shares of the medical equipment provider's stock, valued atMay 11, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Increases Stock Holdings in ResMed Inc. (NYSE:RMD)Charles Schwab Investment Management Inc. boosted its position in shares of ResMed Inc. (NYSE:RMD - Free Report) by 5.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 863,289 shares of the medical equipmentMay 11, 2024 | americanbankingnews.comMichael J. Farrell Sells 14,683 Shares of ResMed Inc. (NYSE:RMD) StockMay 10, 2024 | insidertrades.comInsider Selling: ResMed Inc. (NYSE:RMD) CEO Sells 14,683 Shares of StockMay 10, 2024 | marketbeat.comNational Bank of Canada FI Buys 3,802 Shares of ResMed Inc. (NYSE:RMD)National Bank of Canada FI boosted its stake in shares of ResMed Inc. (NYSE:RMD - Free Report) by 11.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 38,194 shares of the medical equipment provider's stock after buying an additional 3,802 shares duringMay 9, 2024 | marketbeat.comResMed Inc. (NYSE:RMD) CEO Sells $3,178,869.50 in StockResMed Inc. (NYSE:RMD - Get Free Report) CEO Michael J. Farrell sold 14,683 shares of the company's stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $216.50, for a total value of $3,178,869.50. Following the completion of the transaction, the chief executive officer now directly owns 440,752 shares in the company, valued at $95,422,808. The sale was disclosed in a filing with the SEC, which can be accessed through this link.May 7, 2024 | msn.comHere's How Much You'd Have If You Invested $1000 in ResMed a Decade AgoMay 7, 2024 | finance.yahoo.comResMed Announces Participation in the RBCCM Global Healthcare ConferenceMay 7, 2024 | marketbeat.comLos Angeles Capital Management LLC Acquires 11,685 Shares of ResMed Inc. (NYSE:RMD)Los Angeles Capital Management LLC lifted its holdings in shares of ResMed Inc. (NYSE:RMD - Free Report) by 647.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,491 shares of the medical equipment provider's stock afteMay 6, 2024 | marketbeat.comWelch & Forbes LLC Reduces Position in ResMed Inc. (NYSE:RMD)Welch & Forbes LLC reduced its position in shares of ResMed Inc. (NYSE:RMD - Free Report) by 2.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 310,540 shares of the medical equipment provider's stock after selling 6,862 shaMay 5, 2024 | marketbeat.comSwiss National Bank Sells 12,700 Shares of ResMed Inc. (NYSE:RMD)Swiss National Bank cut its holdings in shares of ResMed Inc. (NYSE:RMD - Free Report) by 2.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 459,900 shares of the medical equipment provider's stock after selling 12,700 shares during the period. SwMay 1, 2024 | finance.yahoo.comResMed Third Quarter 2024 Earnings: Beats ExpectationsMay 1, 2024 | insidertrades.comResMed Inc. (NYSE:RMD) Director Karen Drexler Sells 425 SharesApril 30, 2024 | marketbeat.comSivik Global Healthcare LLC Buys New Position in ResMed Inc. (NYSE:RMD)Sivik Global Healthcare LLC bought a new position in ResMed Inc. (NYSE:RMD - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 20,000 shares of the medical equipment provider's stock, valued at approximately $3,440,000. Other laApril 30, 2024 | marketbeat.comInsider Selling: ResMed Inc. (NYSE:RMD) Director Sells 425 Shares of StockResMed Inc. (NYSE:RMD - Get Free Report) Director Karen Drexler sold 425 shares of the business's stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $214.92, for a total value of $91,341.00. Following the completion of the sale, the director now directly owns 8,446 shares of the company's stock, valued at approximately $1,815,214.32. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.April 30, 2024 | fool.comResMed Triumphs in Q3 With Strong EarningsApril 30, 2024 | benzinga.com(RMD) - Analyzing ResMed's Short InterestApril 29, 2024 | marketbeat.comResMed (NYSE:RMD) Shares Down 3% After Analyst DowngradeResMed (NYSE:RMD) Stock Price Down 3% After Analyst DowngradeApril 28, 2024 | msn.comWhy is the ResMed share price surging again and up 14% in two sessions?April 27, 2024 | seekingalpha.comResMed Inc. (RMD) Q3 2024 Earnings Call TranscriptApril 27, 2024 | marketbeat.comResMed Inc. (NYSE:RMD) Stake Increased by C WorldWide Group Holding A SC WorldWide Group Holding A S lifted its holdings in ResMed Inc. (NYSE:RMD - Free Report) by 37.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 98,309 shares of the medical equipment provider's stock after bApril 27, 2024 | marketbeat.comResMed Inc. Announces Quarterly Dividend of $0.48 (NYSE:RMD)ResMed Inc. (NYSE:RMD) announced a quarterly dividend on Thursday, April 25th. Stockholders of record on Thursday, May 9th will be given a dividend of 0.48 per share by the medical equipment provider on Thursday, June 13th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 0.88%. The ex-dividend date of this dividend is Wednesday, May 8th.April 26, 2024 | wsj.comResMed Stock Jumps After Earnings, Revenue BeatsApril 26, 2024 | marketbeat.com6,513 Shares in ResMed Inc. (NYSE:RMD) Purchased by Stevens Capital Management LPStevens Capital Management LP purchased a new position in ResMed Inc. (NYSE:RMD - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 6,513 shares of the medical equipment provider's stock, valued at approximately $1,120,000. SeveralApril 26, 2024 | investopedia.comS&P 500 Gains and Losses Today: Resmed Soars Amid Strong Demand for Sleep DevicesApril 26, 2024 | marketbeat.comResMed (NYSE:RMD) Given New $200.00 Price Target at OppenheimerOppenheimer reduced their price objective on ResMed from $205.00 to $200.00 and set an "outperform" rating on the stock in a research note on Friday.April 26, 2024 | marketbeat.comResMed (NYSE:RMD) Price Target Raised to $200.00 at Royal Bank of CanadaRoyal Bank of Canada increased their target price on ResMed from $187.00 to $200.00 and gave the company a "sector perform" rating in a report on Friday.April 26, 2024 | fool.comWhy ResMed Stock Is Soaring TodayApril 26, 2024 | marketbeat.comResMed (NYSE:RMD) Shares Gap Up After Better-Than-Expected EarningsResMed (NYSE:RMD) Shares Gap Up Following Earnings BeatApril 26, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)April 26, 2024 | markets.businessinsider.comAustralian Stocks: ResMed (RMD) Shares Surge on Robust Q3 ResultsApril 26, 2024 | benzinga.comResMed Analysts Boost Their Forecasts After Better-Than-Expected EarningsApril 26, 2024 | barrons.comResMed Stock Soars After Strong Earnings. Wall Street Thinks It Can Do Even Better.April 26, 2024 | finance.yahoo.comResMed Inc (RMD) Q3 2024 Earnings Call Transcript Highlights: Strong Financial Performance and ...April 26, 2024 | msn.comResMed share price jumps 10% on strong quarterly updateApril 25, 2024 | seekingalpha.comResMed Inc. 2024 Q3 - Results - Earnings Call PresentationApril 25, 2024 | investorplace.comRMD Stock Earnings: ResMed Beats EPS, Beats Revenue for Q3 2024April 25, 2024 | markets.businessinsider.comResmed Inc Q3 Profit Increases, beats estimatesApril 25, 2024 | finance.yahoo.comResMed Inc (RMD) Q3 Fiscal 2024 Earnings: Surpasses Analyst Expectations with Strong GrowthApril 25, 2024 | marketbeat.comResMed (NYSE:RMD) Releases Quarterly Earnings Results, Beats Estimates By $0.22 EPSResMed (NYSE:RMD - Get Free Report) announced its quarterly earnings results on Thursday. The medical equipment provider reported $2.13 EPS for the quarter, beating analysts' consensus estimates of $1.91 by $0.22. The company had revenue of $1.20 billion during the quarter, compared to analysts' expectations of $1.17 billion. ResMed had a return on equity of 23.86% and a net margin of 19.77%. ResMed's revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the company earned $1.68 EPS. Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. RMD Media Mentions By Week RMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RMD News Sentiment▼0.950.50▲Average Medical News Sentiment RMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RMD Articles This Week▼127▲RMD Articles Average Week Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Baxter International News Today Insulet News Today DexCom News Today Teleflex News Today Becton, Dickinson and Company News Today Boston Scientific News Today Stryker News Today West Pharmaceutical Services News Today Shockwave Medical News Today Solventum News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RMD) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsProtect Your Bank Account Before It’s Too LateWeiss RatingsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
